ABSTRACT
PurposeSmart furniture is an essential part of research that has been designed to best complement easy and safe human interaction. The purpose of smart furniture is to save the space of the house and make the products unique, awesome and safe, functional, strong and also make it works better so the people can live better with it. This research aims to explore the key supply chain strategies implemented by the Indian smart furniture industry to reduce the impact of a post-COVID-19 pandemic.Design/methodology/approachThis work utilized a case study and conducted semi-structured interviews with the top leadership of the smart furniture manufacturing industry to explore key supply chain strategies to reduce the influence of the post-COVID-19 pandemic. Additionally, key supply chain strategies have been analyzed using a multi-criteria decision-making technique known as grey relational analysis (GRA) to determine their ranking significance in the smart furniture industry.FindingsThe results of this study discovered that "Inventory-Categorization” is essential in ensuring business continuity during the COVID-19 pandemic and helps reduce the amount of stock they have on hand. It enhanced the opportunity for employees to properly focus on their work and an opportunity for better work-life balance. The results of the study can also help supply chain stakeholders in their establishment of critical strategies.Research limitations/implicationsThe implications of this research work help the Indian furniture industry to make supply chain investment decisions that benefit the organization to sustain itself.Originality/valueThis is the first study to explore key supply chain strategies for the post-COVID-19 era. This work will assist managers and practitioners in helping the organization decide which supply chain strategies are more critical to the betterment of the organization.
ABSTRACT
BACKGROUND: The potential effects of time factor and albuminuria on the morbid alterations in patients with type 2 diabetes (T2D) and COVID-19 are still unclear. We aimed to address the morbid alterations and the potential effects of time factor and albuminuria on the patients' characteristics before, during, and 1 year after COVID-19 recovery. METHODS: 83 patients with T2D were included, at Mansoura University Hospital, Egypt (July 2021-December 2021). Data of detailed history, physical examination, laboratory tests were recruited from files of the patients. Diagnosis and resolution of COVID-19 were established by Real time polymerase chain reaction (RT-PCR) test of SARS-CoV2. Complete blood count (CBC), renal and hepatic function tests, multiple measures of morning spot urine albumin to creatinine ratio (urine ACR), glycosylated hemoglobin (HBA1c), lipid profile, erythrocyte sedimentation rate (ESR), C-reactive protein (CRP), Ferritin, neutrophil to lymphocyte ratio (NLR), vitamin D3, intact parathyroid hormone (intact PTH), serum calcium were applied to all participants. RESULTS: Our participants had a mean age of 45 years, 60.2% male, 56.6% were hospitalized, and 25.3% were admitted to ICU for severe COVID-19. Albuminuria was prevalent in 71.1% before, 98.8% during, and 92.8% after COVID-19 recovery. Patients with albuminuria showed older age, longer duration of T2D, more frequent severe COVID-19 and hospitalization (p = 0.03, p < 0.001, p = 0.023& p = 0.025) respectively. Body mass index (BMI), mean arterial blood pressure, ESR, CRP, ferritin, NLR, HBA1c, triglycerides to high-density lipoprotein cholesterol (TG/HDL-C) ratio, vitamin D3, serum calcium, alkaline phosphatase (ALP), hepatic aminotransferases, and urine ACR showed significant alterations throughout the study (p < 0.001 for all). Although the interaction between time and albuminuria showed non-significant effect on all studied parameters, we noticed relevant main effects of time factor on Body mass index (BMI), HBA1c, glomerular filtration rate (eGFR), TG/HDL ratio, NLR, vitamin D3, (p < 0.001 for all). Moreover, albuminuria showed main effects on BMI, serum creatinine, and intact PTH (p = 0.019, 0.005 & <0.001), respectively. CONCLUSION: The characteristics of patients with T2D significantly altered throughout the study. Time factor and albuminuria exerted relevant main effects on the patients' characteristics without significant effect of their interaction.
ABSTRACT
A plethora of evidence links SARS-CoV-2 infection with concomitant cognitive dysfunction, which often persists weeks to months after the acute stages of illness and affects executive function, attention, memory, orientation, and movement control. It remains largely unclear which conditions or factors exacerbate the recovery. In a cohort of N=37 Slovenian patients (5 females, aged M = 58, SD = 10.7 years) that were hospitalized because of COVID-19, the cognitive function and mood states were assessed immediately after discharge and 2-months later to investigate the early post-COVID recovery changes. We assessed the global Montreal Cognitive Assessment (MoCA), Simple and Choice Reaction Times, executive functions (Trail-Making Test - TMT-A and TMT-B), short-term memory (Auditory Verbal Learning Test - AVLT), and visuospatial memory. We monitored depressive and anxiety symptoms and applied general self-efficacy and cognitive complaints questionnaires. Our results showed a global cognitive impairment (MoCA, Z = 332.5; p = 0.012), poorer performance on executive functions (TMT-A, Z = 188; p = 0.014; and TMT-B, Z = 185; p = 0.012), verbal memory (AVLT, F = 33.4; p < 0.001), and delayed recall (AVLT7, F = 17.1; p < 0.001), and higher depressive (Z = 145; p = 0.015) and anxiety (Z = 141; p = 0.003) symptoms after hospital discharge compared to 2-month follow-up, indicating that SARS-CoV-2 may transiently impair cognitive function and adversely affect the mood. No improvement in MoCA was observed in 40.5% of the patients at follow-up, indicating possible long-term effects of COVID-19 on global cognitive performance. Medical comorbidities (p = 0.035) significantly predicted the change in MoCA score over time, while fat mass (FM, p = 0.518), Mediterranean diet index (p = .0.944), and Florida Cognitive Activities Score (p = 0.927) did not. These results suggest that the patients' medical comorbidities at the time of SARS-CoV-2 infection could importantly contribute to the acute impairment of cognitive function and stress the importance of systemic implementation of countermeasures to limit the negative consequences on public health.
ABSTRACT
Job creation is paramount when considering global transitions to low-carbon, clean-energy solutions. The building sector, critical to reducing greenhouse gas emissions on a global scale, has technologies available that rely on electricity rather than fossil fuels for energy and indoor heating and cooling. Solar photovoltaic, energy storage in the form of prosumer batteries, and heat pumps represent three readily deployable solutions to reduce carbon emissions in both new and retrofitted buildings. This study investigates the creation of jobs for each solution and then for all three combined across key countries in North America, Europe, and Asia. While other studies have explored aggregated job creation within nations, regions or globally, this first-of-a-kind study employs a micro-level approach examining six individual building archetypes: residential, hospital, hotel, office, retail, and education. Using the best available data as of 2022, the first-order assessment finds that more than 2 million new jobs and more than 141 million job years can be generated in Europe and the United States alone during the transition to net zero living.
ABSTRACT
Background Post-COVID-19 syndrome, also known as long COVID, is a disorder that has many characteristics, one of which is chronic fatigue following acute infection with the SARS-CoV-2 virus. Methodology We distributed a web-based survey among patients diagnosed with COVID-19 across the world and collected 190 responses regarding their demographics, histories, COVID-19 infection courses, and common symptoms. Results We found that about 85.3% of the patients experienced some form of symptom following recovery from the infection. Among the reported symptoms, 59% of patients experienced fatigue or lethargy, 48.9% reported decreased stamina, 32.6% reported shortness of breath, 16.8% had a persistent cough, and 23.7% experienced anxiety following recovery from COVID-19. Conclusions Reported symptoms closely resembled myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS); however, a deeper biochemical understanding of ME/CFS is required to confirm causation.
ABSTRACT
The COVID-19 pandemic has created an unprecedented crisis. The pandemic poses a significant threat to human security and existing developmental challenges, compelling emergency spending on saving lives and securing livelihoods. Despite being in the ongoing traumatic phases of the global pandemic, the world is further expected to face undue developmental challenges due to the fourth industrial revolution and climate change. In a massive effort to save the global economies and protecting livelihoods, national governments had been obliged to announce stimulus (fiscal) packages and create local and regional funds to boost up domestic production and ensure food, water, and energy security. This chapter intends to provide a broader overview of the implications of fiscal stimulus toward sustainable recovery and address post-COVID-19 developmental challenges in a cross-country setting. Although expectantly incentivizing through fiscal policies will mobilize food security, public health, climate security and environment, migrant worker and urban resilience, gender, education, and facilitate attainment of the respective sustainable development goals (SDGs);sustainable recovery could largely vary based upon national resilience and the extant developmental framework. © The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer 2022.
ABSTRACT
The relationship between initial COVID-19 infection and the development of long COVID remains unclear. The purpose of this study was to compare the experience of long COVID in previously hospitalized and non-hospitalized adults in a community-based, cross-sectional telephone survey. Participants included persons with positive COVID-19 test results between 21 March 2021 and 21 October 2021 in Alberta, Canada. The survey included 330 respondents (29.1% response rate), which included 165 previously hospitalized and 165 non-hospitalized individuals. Significantly more previously hospitalized respondents self-reported long COVID symptoms (81 (49.1%)) compared to non-hospitalized respondents (42 (25.5%), p < 0.0001). Most respondents in both groups experienced these symptoms for more than 6 months (hospitalized: 66 (81.5%); non-hospitalized: 25 (59.5), p = 0.06). Hospitalized respondents with long COVID symptoms reported greater limitations on everyday activities from their symptoms compared to non-hospitalized respondents (p < 0.0001) and tended to experience a greater impact on returning to work (unable to return to work-hospitalized: 20 (19.1%); non-hospitalized: 6 (4.5%), p < 0.0001). No significant differences in self-reported long COVID symptoms were found between male and female respondents in both groups (p > 0.05). This study provides novel data to further support that individuals who were hospitalized for COVID-19 appear more likely to experience long COVID symptoms.
ABSTRACT
The SARS-CoV-2 virus causes a contagious disease known as Coronavirus Disease 2019 (COVID-19). It began spreading globally in 2019 and is still producing pandemics today. Different COVID-19 vaccinations offer protection against this illness. Pfizer-BioNTech and Sinopharm were the two vaccine manufacturers with the highest usage in Iraq. Both vaccines use a different method to activate the immune system. This study seeks to compare the IL-22, IL-37, and IL-38 levels in those who received either the Sinopharm or the Pfizer-BioNTech COVID-19 vaccination. IL-22, IL-37, IL-38 levels have been shown to be upregulated in COVID-19 patients. In this study, IL-22, IL-37, and IL -38 levels were tested in 80 healthy controls and 100 COVID-19 patients 14-21 days after recovery. Additionally, people who received the Sinopharm or Pfizer-BioNTech vaccine (50 each) were monitored 21 days after the first dosage and 21 days after the second dose. In comparison to controls, serum levels were noticeably higher in recovered patients. Except for the first dosage of Pfizer BioNTech, the first and second doses of Sinopharm and Pfizer BioNTech were linked to considerably higher levels of IL-22, IL-37, and IL-38 compared to controls or recovered patients. where IL-22, IL -37, and IL-38 levels did not show significant differences compared to recovered patients. In conclusion, lower IL-37 and IL-38 molecule levels were linked to recovery from COVID-19, although these levels remained considerably greater in recovered patients compared to uninfected controls. Vaccination with Sinopharm or Pfizer-BioNTech confirmed the up-regulating effects of SARS-CoV-2 on IL-22, IL-37, and IL-38 levels.
ABSTRACT
The aim of this research is to analyze the potential impact of the COVID-19 infection on the serum biochemical concentration of children 6 months after recovery from the infection. The study included 72 children with a median age of 11 years. The case group consisted of 37 children who had contracted COVID-19 6 months prior to the analysis. They reported no other pre- or post-covid chronic or systemic diseases. The control group consisted of 35 children who had no prior record of COVID-19 infection. The analysis showed a substantial variation (P = 0.026) in the mean urea values (mmol/L) between the case group (4.513 ± 0.839) and the control group (5.425 ± 1.173). However, both groups' urea levels were within the normal range of their age group. No statistical differences were found analyzing the variations between the two groups in the levels of LDH, AST, ALT, BiliT, GGT, AlbBCG2, CRP, CK, AlKP, UA, Phos, Crea2, Gluc, Ca, Na, K, Cl, TP, TC, TG, and HDL (P > 0.05). The DMFT score was substantially greater (P < 0.002) in the infected team (5.38 ± 2.841) in comparison to the non-infected group (2.6 ± 2.257). The study indicates that COVID-19 infection does not leave biochemical alterations among children who did not have pre-existing conditions. The biochemical analysis suggests that children recover better than adults from COVID-19. Furthermore, it calls for investigating non-lethal COVID-19 infection as a tool to discover underlying conditions. The DMFT score shows a correlation between COVID-19 infection and caries. However, the nature of the correlation is yet to be investigated.
ABSTRACT
This article describes and discusses the spread of the coronavirus pandemic in Australia, its impact on people and the economy and policy responses to these impacts. It discusses the implications of these responses for post-pandemic recovery, though noting that the country's response to the coronavirus disease 2019 (COVID-19) pandemic has, thus far, been among the most successful in the world. Australia's early physical distancing measures, relatively high per capita testing rates, political stability, national wealth and geographic isolation are among the explanatory factors. This article summarises Australia's socio-economic responses to the pandemic and shows what this means, especially, for vulnerable groups, and thereby for social inequality, which the pandemic has aggravated and which may become more apparent, still, as debates about paths to economic and social recovery are in some respects already polarising. Although it is relatively early to clearly identify lessons learnt from these responses, it is safe to conclude that further policy development needs to be carefully focused to avoid exacerbating existing inequalities.
ABSTRACT
The SARS-CoV-2 virus causes a contagious disease known as Coronavirus Disease 2019 (COVID-19). It began spreading globally in 2019 and is still producing pandemics today. Different COVID-19 vaccinations offer protection against this illness. Pfizer-BioNTech and Sinopharm were the two vaccine manufacturers with the highest usage in Iraq. Both vaccines use a different method to activate the immune system. This study seeks to compare the IL-22, IL-37, and IL-38 levels in those who received either the Sinopharm or the Pfizer-BioNTech COVID-19 vaccination. IL-22, IL-37, IL-38 levels have been shown to be upregulated in COVID-19 patients. In this study, IL-22, IL-37, and IL-38 levels were tested in 80 healthy controls and 100 COVID-19 patients 14-21 days after recovery. Additionally, people who received the Sinopharm or Pfizer-BioNTech vaccine (50 each) were monitored 21 days after the first dosage and 21 days after the second dose. In comparison to controls, serum levels were noticeably higher in recovered patients. Except for the first dosage of Pfizer BioNTech, the first and second doses of Sinopharm and Pfizer BioNTech were linked to considerably higher levels of IL-22, IL-37, and IL-38 compared to controls or recovered patients. where IL-22, IL-37, and IL-38 levels did not show significant differences compared to recovered patients. In conclusion, lower IL-37 and IL-38 molecule levels were linked to recovery from COVID-19, although these levels remained considerably greater in recovered patients compared to uninfected controls. Vaccination with Sinopharm or Pfizer-BioNTech confirmed the up-regulating effects of SARS-CoV-2 on IL-22, IL-37, and IL-38 levels.Copyright © 2023, Codon Publications. All rights reserved.
ABSTRACT
Southeast Asia is one of the world's most energy-intensive and climate vulnerable regions, with rapid urbanization and industrialization increasing its greenhouse gas emissions and a high exposure to extreme weather events. The COVID-19 pandemic has had a massive impact on the region's economic growth. Decisions taken by leaders today to revive economies will either entrench the region's dependence on fossil fuels or accelerate decarbonization efforts to achieve the Paris Agreement and the Sustainable Development Goals. This article recalls the imperative of a green, climate resilient recovery from the COVID-19 pandemic to put ASEAN economies on a sustainable and inclusive development path before discussing the chronic infrastructure investment gap and reviewing options to catalyze climate investment to address this gap and finance recovery efforts. © 2023 American Institute of Chemical Engineers.
ABSTRACT
PurposeThe purpose of this paper is to investigate the potential synergy between companies' sustainable supply chain management (SSCM) activities and their supply chain resilience (SCRES). The authors propose hypotheses about the impact of buying companies SSCM activities on the inflicted damage by unexpected supply chain disruptions and the recovery time afterwards and test these empirically using data from companies during the global COVID-19 pandemic.Design/methodology/approachThe authors investigate a sample of 231 of the largest publicly traded companies in the European Union with 4.158 firm-year observations. For the analysis, the authors generate variables capturing the companies' intensity and years of experience of their SSCM activities targeted at the supply chain and run regression analyses on the inflicted damage due to the COVID-19 pandemic and the recovery time after the disruption.FindingsBuying companies' SSCM activities have a positive effect on their SCRES. The damage inflicted by unexpected supply chain disruptions is lower when companies have higher levels of SSCM and longer experience with it. The recovery time afterwards is significantly reduced by longer experience with SSCM efforts.Research limitations/implicationsThe authors suggest SCRES is reinforced by transparency, situational awareness, social capital and collaboration resulting from companies SSCM activities translate into increased SCRES.Practical implicationsThe authors show that companies with superior SSCM are more resilient in a crisis and conclude that, therefore, companies should invest in SSCM to prevent future supply disruptions.Originality/valueTo the best of the authors' knowledge, this is the first empirical study analyzing a data set of multi-industry companies, linking their SSCM activities to SCRES during the pandemic.
ABSTRACT
Vietnam in 2022 was beset with numerous dramatic political developments and diplomatic uncertainties but also recorded significant economic achievements. Changes in the top echelons of power took place in an unprecedented manner due to the intensifying anticorruption campaign, exposing the malleability of elite Vietnamese governing institutions and shrinking the space for civil society organizations. Meanwhile, Vietnam was recognized for its outstanding recovery from the COVID-19 pandemic with remarkable economic performance. The country's "bamboo diplomacy” was put under stress amid challenges caused by Russia's invasion of Ukraine and the US–China strategic rivalry. Navigating the turbulence and uncertainty of domestic and international affairs while maintaining the momentum of economic recovery will be the main challenge for Vietnam in 2023.
ABSTRACT
This study attempts to reveal the consequences of coronavirus disease 2019 (COVID-19) on micro, small, and medium enterprises (MSMEs) in Chiang Mai, Thailand. A total of 786 MSMEs were surveyed during May and August 2022, corresponding to the period when the recovery of businesses and livelihoods from the ongoing COVID-19 crisis became more perceptible. The perceptions of COVID-19's impact on MSMEs and their survivability are explored and investigated. To achieve this goal, a copula-based sample selection survival model is introduced. This idea of the model is extended from the concept of the Cox proportional hazards model and copula-based sample selection model, enabling us to construct simultaneous equations—namely, the probability-of-failure equation (selection equation) and the duration-of-survival equation (time-to-event or outcome equation). Several copula functions with different dependence patterns are considered to join the failure equation and the duration-of-survival equation. By comparing the Akaike and Bayesian information criteria values of the candidate copulas, we find that Farlie–Gumbel–Morgenstern (FGM) copula performs the best-fit joint function in our analysis. Empirically, the results from this best-fit model reveal that the survival probability of MSMEs in the next year is around 80%. However, some MSMEs may not survive more than three months after the interview. Finally, our results also reveal that the tourism MSMEs have a lower chance of survival than the commercial and manufacturing MSMEs. Notably, the business size and the support schemes from the government—such as the debt restructuring process, the tax payment deadline extension, and the reduced social security contributions—exhibited a role in lengthening the survival duration of the non-surviving MSMEs. [ABSTRACT FROM AUTHOR] Copyright of Mathematics (2227-7390) is the property of MDPI and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
ABSTRACT
The article examines the implications held by the EU's response to the COVID-19 pandemic for the green transition as set by the European Green Deal. It distinguishes changes in: (a) the use of policy instruments;(b) governance principles;and (c) the prioritising of policy goals as expressed via the conceptual framework of orders of change. The article assesses the extent of these changes as well as the patterns and regional variations among EU Member States, together with the Commission's role in pushing for preferential energy policy choices and encouraging the Member States' ambitions. The analysis shows the EU Energy Union governance framework was promoting the EU's climate targets' full integration into the EU's energy transition policy instruments (first order of change) even before the European Green Deal. Still, the EU's response to the COVID-19 crisis created strong financial and policy leverage to accelerate the green transition and gave an opportunity to close the gap between less ambitious and more ambitious EU countries. Many countries traditionally reliant on EU funds seized this opportunity, demonstrating the role of changed governance principles (the second order of change). However, the crisis has had an evolutionary impact, not a revolutionary one. While coherence between the energy and climate goals remains high, the EU's energy transition is falling short in fully integrating biodiversity (which would constitute a full paradigmatic, third-order change), despite this being an essential component of the EU's green transition.
ABSTRACT
Feminists and other progressives have long argued that global macroeconomic governance is deeply deficient. The deficiencies have been revealed and amplified by the COVID-19 crisis. The need to radically reconstruct the global economic governance architecture is therefore pressing. Albert Hirschman's conception of "possibilism” is particularly relevant for navigating these challenges. In the spirit of Hirschmanian possibilism, I make a case for what I refer to as "enabling global financial governance.” I use this term to refer to reforms of global financial governance that could provide a supporting environment for feminist and other progressive plans for sustainability and social justice. I advance the provocative claim that feminists and other social justice advocates should embrace what I term "permissive multilateralisms” rather than "harmonized multilateralism.” I also highlight a number of directions for global financial governance reform that could provide policy space for progressive initiatives, including those advanced by feminists. I offer this paper as a small way of honoring my friend, Eugenia Correa, whose intellectual legacy and commitment to engaged scholarship has influenced me profoundly.
ABSTRACT
Purpose - Smart furniture is an essential part of research that has been designed to best complement easy and safe human interaction. The purpose of smart furniture is to save the space of the house and make the products unique, awesome and safe, functional, strong and also make it works better so the people can live better with it. This research aims to explore the key supply chain strategies implemented by the Indian smart furniture industry to reduce the impact of a post-COVID-19 pandemic. Design/methodology/approach - This work utilized a case study and conducted semi-structured interviews with the top leadership of the smart furniture manufacturing industry to explore key supply chain strategies to reduce the influence of the post-COVID-19 pandemic. Additionally, key supply chain strategies have been analyzed using a multi-criteria decision-making technique known as grey relational analysis (GRA) to determine their ranking significance in the smart furniture industry. Findings - The results of this study discovered that "Inventory-Categorization" is essential in ensuring business continuity during the COVID-19 pandemic and helps reduce the amount of stock they have on hand. It enhanced the opportunity for employees to properly focus on their work and an opportunity for better work-life balance. The results of the study can also help supply chain stakeholders in their establishment of critical strategies. Research limitations/implications - The implications of this research work help the Indian furniture industry to make supply chain investment decisions that benefit the organization to sustain itself. Originality/value - This is the first study to explore key supply chain strategies for the post-COVID-19 era. This work will assist managers and practitioners in helping the organization decide which supply chain strategies are more critical to the betterment of the organization.
ABSTRACT
The coronavirus disease 2019 (COVID-19) continues to be a devastating disease for the elderly population, especially in long-term care facilities, and it presents with varying clinical presentations. We have ample evidence that COVID-19 can predispose to deep vein thrombosis (DVT) and pulmonary embolism (PE) during an active infection. Still, very few cases of DVT have been reported after recovery from COVID-19. The imbalance of the coagulation cascade and the increased release of certain coagulation factors play an essential role in promoting hypercoagulability and vascular endothelial dysfunction. It leads to a rise in the level of fibrin degradation products, D-dimers, which can remain elevated for up to several weeks, even after recovery. It has been suggested that the risk of DVT occurring after recovering from COVID-19 remains high for up to three months. We report a case of a 77-year-old long-term care female resident at a nursing facility, ambulatory at baseline, who was noted to be COVID-19 positive upon routine facility-wide testing per department of health guidelines. She was asymptomatic during her 10-day quarantine period. D-dimer levels during routine labs were high (initial D-dimer level of 1.87 mg/L FEU {normal value: 0.19-0.52 mg/L FEU}), but the patient had no clinical signs and symptoms of DVT. Ultrasound of the bilateral legs was not performed due to low clinical suspicion. The patient received an enoxaparin DVT prophylaxis dose during the quarantine period. Follow-up D-dimer levels were done at frequent intervals after recovery, but D-dimer levels continued to remain elevated up till six weeks after her 10-day quarantine period ended. Based on previous experience with other long-term care residents who suffered from COVID-19, bilateral lower extremity ultrasound was performed, which showed bilateral DVT. Elevated D-dimer levels are a predictor of hypercoagulation complications in COVID-19. Patients with persistently elevated D-dimer levels after recovery from COVID-19 should be screened for thromboembolic complications, even if they are asymptomatic. DVT can occur up to three months post-recovery from COVID-19 infection.